ArticleInvestigative and clinical urology2026
Analysis of uroflowmetry results in community-dwelling adult males: Results of 24 years of Korean population-based screening data.
Article in Investigative and clinical urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIn this study, we aimed to analyze the uroflowmetry findings in community-dwelling adult males and examine the relationship between maximum urine flow rate (Qmax) and factors such as age, prostate size, International Prostate Symptom Score (IPSS), prostate-specific antigen (PSA), and voided volume. MATERIALS AND
methodsData were collected from 75,199 males aged >24 years through community health screenings conducted by the Korea Prostate & Voiding Health Association. After applying the exclusion criteria, 12,891 males with complete data were included in this analysis. Uroflowmetry, IPSS, transrectal ultrasonography, and PSA tests were performed.
resultsThe mean patient age was 74.66±9.10 years, mean IPSS was 14.59±8.11, mean prostate size was 30.50±14.44 mL, mean PSA was 1.79±3.94 ng/mL, and mean Qmax was 14.21±6.34 mL/s. Significant associations were found between Qmax and age (p<0.001), IPSS (p<0.001), prostate size (p<0.001), PSA level (p<0.001), and voided volume (p<0.001). Qmax decreased with increasing age, IPSS, prostate size, and PSA, but increased with larger voided volumes.
conclusionsThis large-scale community-based study provides valuable insights into the relationship between uroflowmetry results and various factors in adult males. These findings can serve as a reference for evaluating uroflowmetry results in clinical settings and contribute to a better understanding of lower urinary tract symptoms in the general male population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.